case_images: PMC6885825_01
case_images: Results of prolonged 75-g OGTT with measurements at timepoints before and after TU administration.
case_images: CRIE2019-9616125.001.jpg
case_images: PMC6885825_01_CRIE2019-9616125.001.jpg
case_images: fig1
case_images: Vildagliptin was discontinued and the patient was asked to undergo a prolonged oral glucose tolerance test (OGTT) with blood glucose measurements at various timepoints, prior to and 48 hours after the next administration of testosterone. (Table 1, Figure 1).